[1]
R. A. Meléndez Guevara and A. Y. Asencio Aguedo, “Clinicopathological factors associated with the amplification of the HER2 /neu gene in patients with breast cancer HER2 2+”, An Fac med, vol. 78, no. 4, pp. 381–385, Mar. 2018, doi: 10.15381/anales.v78i4.14257.